focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHRM.L Regulatory News (PHRM)

  • There is currently no data for PHRM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Operational Update

21 Apr 2015 16:22

RNS Number : 9044K
Phorm Corporation Limited
21 April 2015
 

 

21 April 2015

 

Phorm Corporation Limited

("Phorm" or the "Company")

Operational Update

Phorm (AIM: PHRM), a leading internet personalisation technology company, is pleased to announce an unaudited operational update.

Highlights:

· Commercial operations commenced in the US

· Strong growth in sales and sales pipeline in Russia

· Potential partnership discussions progressing in China

· Significant performance improvements following the release of new algorithms

· Second phase of major cost reduction programme initiated

On 16 January 2015, Phorm announced that it was continuing to make very good progress in respect of the group's key performance indicators. The Company is pleased to announce continued progress with the recent commencement of commercial operations in the United States of America ("US").

The US is the world's largest online advertising market; according to PricewaterhouseCoopers, in 2015, it will be worth approximately US$52bn. Accordingly, the Company believes the commercial prospects for its market leading technology in the US are most promising and has been encouraged by the rapid growth in unique users achieved within the first month of commercial operations. In addition, in terms of inventory, the Company now has access to over 9bn advertising requests per day in the US.

Phorm has also experienced strong revenue growth in Russia, despite the challenging macro economic conditions prevalent in this market. The unaudited gross revenue derived from Russia in March 2015 was in excess of RUB8m and the Company expects this growth to accelerate significantly based on its current sales pipeline.

Russian Operations Gross Revenue

 

Date

Gross Revenue (RUB)

Aug 2014

202,418

Sep 2014

1,301,292

Oct 2014

2,105,801

Nov 2014

2,045,712

Dec 2014

5,633,268

Jan 2015

3,231,175

Feb 2015

4,493,894

Mar 2015

8,016,510

 

In China, the Company has encountered a number of operational challenges and has therefore concluded that the most effective and expedient means to achieve its objectives in this particular market is through the establishment of a potential partnership with a large local player. Several conversations are currently ongoing and the Company will update the market in due course as such discussions progress.

On 16 January 2015, the Company also announced that it had launched its machine learning algorithm. Through its relationships with Internet Service Providers ("ISPs"), Phorm has access to substantial amounts of data, which it is able to analyse anonymously and in real time. The machine learning algorithms have already provided a significant increase in both the efficiency and performance of Phorm's technology. The efficiency improvements arise from the way in which the algorithm informs the prices of the bids on real time bidding platforms, where there have been increases of approximately 300 per cent. The performance improvements stem from the manner in which the algorithm can anonymously spot user buying patterns. The performance improvements achieved have been as high as 350 per cent.

By improving both performance and efficiency, whilst reducing the amount of manual input required, the machine learning algorithm has also opened up the possibility of concluding potential licensing agreements with third parties in order to further accelerate the commercialisation of the platform. A number of these discussions are ongoing and the Company currently anticipates being able to announce its first licencing deal in the coming months.

The first phase of the Company's previously announced cost reduction exercise has also been successfully completed and the Company is now implementing a second phase which, in part due to the operational efficiencies created by the abovementioned machine learning algorithm, should achieve further annualised cost savings of approximately US$400-600k.

The combination of our commercial launch in the US, together with strong revenue growth in Russia, ongoing partnership discussions in China, enhanced performance and a reducing cost base means that the Company continues to be optimistic about its commercial outlook for the remainder of 2015 and beyond.

-Ends-

For further information please contact:

Phorm Corporation Limited

Andy Croxson (analysts and investors) +44 20 3397 6001

UK Investors

Mirabaud Securities LLP (Broker) +44 20 7321 2508

Jason Woollard

Peter Krens

Strand Hanson Limited (Nominated Adviser) +44 20 7409 3494

James Harris

Matthew Chandler

James Dance

US Investors

Lippert/Heilshorn and Associates (Investor Relations) +1 212 838 3777

John Heilshorn

 

About Phorm

 

Phorm is a global personalisation technology company that makes content and advertising more relevant to the consumer. Phorm's innovative platform preserves user privacy and delivers a more interesting online experience.

 

Phorm's industry leading technology enables its Internet Service Provider ("ISP") partners to offer a new type of online advertising platform and a free consumer internet content feature, ensuring more relevant advertisements and personalised content for opted-in users.

 

Phorm's advertising platform revolutionises current standards of online privacy, fully protecting the identity of consumers. Phorm's solution is completely opt-in. Only those users consenting to the service are profiled and only ever on an anonymous basis.

 

Phorm's partners include leading ISPs, Publishers, Advertising Networks and Advertisers.

 

Phorm, under a predecessor holding company, was admitted to trading on the AIM market of the London Stock Exchange in 2004.

 

For more information, please visit: www.phorm.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEFLFLEZFFBBX
Date   Source Headline
19th Jun 20127:00 amRNSAGM Statement
1st Jun 20127:00 amRNS£20m equity fundraising into Phorm China
1st Jun 20127:00 amRNSIntention to Re-Domicile
22nd May 20127:00 amRNSPhorm Announces AGM Notice & Proposed Board Change
21st Mar 20127:00 amRNSAppointment of Nominated Adviser and Joint Broker
5th Mar 20127:00 amRNSTransfer of Shares
1st Mar 20127:00 amRNSTransfer of Shares
28th Dec 20117:00 amRNSDirector Dealing
12th Dec 201110:10 amRNSTransfer of Shares
7th Dec 201110:19 amRNSTransfer of Shares
2nd Dec 20112:02 pmRNSTR-1: Notification of Major Interest in Shares
2nd Dec 201112:16 pmRNSTransfer of Shares
11th Nov 20117:30 amRNSIssue of Equity
4th Nov 20117:30 amRNSIssue of Equity
21st Oct 20113:28 pmRNSIssue of Equity
20th Oct 20114:14 pmRNSTransfer of Shares
7th Oct 20112:00 pmRNSBlock Admission Return
30th Sep 20117:00 amRNSInterim Results for Six Months Ended 30 June 2011
28th Sep 20117:00 amRNSProduct Launch
30th Jun 20117:00 amRNSAnnual Financial Report
8th Apr 201112:00 pmRNSBlock Admission Return
30th Mar 20117:00 amRNSTR-1: Notification of Major Interest in Shares
22nd Mar 20117:00 amRNSPlacing and operating update
2nd Mar 201112:00 pmRNSTransfer of Shares
1st Feb 201110:14 amRNSResult of AGM
6th Jan 20117:15 amRNSOption Grant and Modification
6th Jan 20117:05 amRNSAdvisory Board Appointment - Juan Villalonga
24th Dec 20108:11 amRNSNotice of AGM
17th Dec 20109:11 amRNSIssue of convertible secured loan notes
8th Oct 20105:25 pmRNSBlock Admission Return
30th Sep 20107:00 amRNSInterim results
22nd Sep 20107:00 amRNSUpdate on Commercial Deployment in Brazil
17th Aug 20103:42 pmRNSCorrection re Share Transfer
16th Aug 20103:58 pmRNSShare Transfer
16th Aug 20108:50 amRNSDirectorate Change
30th Jul 20101:00 pmRNSTransfer of Shares
23rd Jul 201011:17 amRNSDirectorate Change
16th Jul 20104:25 pmRNSTransfer of Shares
9th Jul 20107:00 amRNSTransfer of Shares
7th Jul 20104:55 pmRNSDirector/PDMR Shareholding
7th Jul 20102:19 pmRNSPlacing of Shares
30th Jun 20102:17 pmRNSAnnual Report & Accounts Notification
30th Jun 20107:00 amRNSPreliminary Results
28th Jun 20107:00 amRNSNotification of results
8th Jun 20102:05 pmRNSChange in name of Nominated Adviser
30th Apr 20101:08 pmRNSGrant of options
9th Apr 20105:25 pmRNSBlock Admission Return
26th Mar 20107:00 amRNSCommercial Deployment in Brazil
28th Jan 20104:37 pmRNSNotification of Major Interest in Shares
11th Jan 20104:28 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.